# Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study

> **NCT00976300** · PHASE2 · COMPLETED · sponsor: **Institute of Rheumatology, Prague** · enrollment: 40 (actual)

## Conditions studied

- Systemic Lupus Erythematosus
- Lupus Nephritis

## Interventions

- **DRUG:** Cyclosporine A
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT00976300
- **Lead sponsor:** Institute of Rheumatology, Prague
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2008-05
- **Final completion:** 2009-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2010-06-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00976300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00976300, "Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00976300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*